Fochon Pharmaceuticals, Ltd.
Records under this name other than the patents Fochon Pharmaceuticals, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 8 of 8 · Back to Fochon Pharmaceuticals, Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,091,478 | Apoptosis-Inducing Agents Formerly held In force · High confidence | In force | High confidence | |
| US 12,312,349 | Apoptosis-Inducing Agents Formerly held In force · High confidence | In force | High confidence | |
| US 11,555,042 | Macrocyclic Compounds as TRK Kinases Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 11,459,332 | Substituted 2-Azabicyclo[3.1.0]HEXANES as TRK Kinases Inhibitors Formerly held Lapsed on the fee record Ended Oct 4, 2026 · High confidence | Lapsed on the fee record | Ended Oct 4, 2026 | High confidence |
| US 10,053,449 | Quinazoline Derivatives, Compositions Thereof, and Use as Pharmaceuticals Lapsed on the fee record Ended Aug 21, 2026 · High confidence | Lapsed on the fee record | Ended Aug 21, 2026 | High confidence |
| US 11,168,078 | Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase Formerly held Lapsed on the fee record Ended Nov 9, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 9, 2025 | From the USPTO record |
| US 9,714,235 | Quinazoline Derivatives, Compositions Thereof, and Use as Pharmaceuticals Lapsed on the fee record Ended Jul 25, 2025 · High confidence | Lapsed on the fee record | Ended Jul 25, 2025 | High confidence |
| US 10,894,038 | Indolizine derivatives, composition and methods of use Lapsed on the fee record Ended Jan 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 19, 2025 | From the USPTO record |